surmount-1 tirzepatide Trial Articles & Evidence Briefings |
Description
However, several plausible explanations exist based on the medication's known effects
Early side effects like nausea and bloating are common
These compound formulations are typically only available through compounding pharmacies rather than research peptide vendors like Polaris
The appropriate dose depends on response and tolerability
Faster metabolic responders may experience more acute telogen effluvium
Keep in mind: Starting in April 2026, Medicare and Medicaid may begin covering GLP-1 medications like Zepbound and Mounjaro more broadly, including for obesity-related use
